Femasys Inc. Files 8-K Report
Ticker: FEMY · Form: 8-K · Filed: Mar 20, 2024 · CIK: 1339005
| Field | Detail |
|---|---|
| Company | Femasys Inc (FEMY) |
| Form Type | 8-K |
| Filed Date | Mar 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Financials
TL;DR
Femasys filed an 8-K, likely with financial updates. Keep an eye out for details.
AI Summary
On March 20, 2024, Femasys Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing signals that Femasys Inc. is providing updated information to the SEC, which could include material events or financial disclosures relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without immediate negative or positive financial implications mentioned in the excerpt.
Key Numbers
- 20240320 — Report Date (Date of the 8-K filing)
Key Players & Entities
- FEMASYS INC (company) — Registrant
- 001-40492 (company) — SEC File Number
- 11-3713499 (company) — IRS Employer Identification No.
- 30024 (company) — ZIP Code
- 3950 Johns Creek Court , Suite 100 (company) — Principal Executive Offices Address
FAQ
What specific 'Other Events' are being reported by Femasys Inc. in this 8-K filing?
The provided excerpt does not detail the specific 'Other Events' but indicates this section is part of the filing.
What financial statements or exhibits are included with this 8-K filing?
The excerpt states that 'Financial Statements and Exhibits' are part of the filing, but does not list their specific contents.
When was this 8-K filing submitted to the SEC?
The filing was submitted on March 20, 2024.
What is Femasys Inc.'s principal executive office address?
Femasys Inc.'s principal executive offices are located at 3950 Johns Creek Court, Suite 100, Suwanee, Georgia 30024.
What is the SIC code for Femasys Inc.?
The Standard Industrial Classification (SIC) code for Femasys Inc. is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.
Filing Stats: 435 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2024-03-20 08:18:02
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share FEMY The Nasdaq Stock Mar
Filing Documents
- ef20024684_8k.htm (8-K) — 30KB
- ef20024684_ex99-1.htm (EX-99.1) — 19KB
- 0001140361-24-014239.txt ( ) — 192KB
- femy-20240320.xsd (EX-101.SCH) — 4KB
- femy-20240320_lab.xml (EX-101.LAB) — 22KB
- femy-20240320_pre.xml (EX-101.PRE) — 16KB
- ef20024684_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events On March 20, 2024, Femasys Inc. (the "Company") issued a press release announcing positive topline data from its pivotal trial of FDA-cleared FemaSeed for the treatment of infertility. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Femasys Inc. dated March 20, 2024
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Femasys Inc. By: /s/ Kathy Lee-Sepsick Names: Kathy Lee-Sepsick Title: Chief Executive Officer Date: March 20, 2024